HomeTrialNCT07163260
🔬NCT07163260ENROLLING BY INVITATION

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Study Summary

This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the experience so far in dealing with the condition. This is a survey-based study; hence no medications or other treatments will be provided to participants as a part of this study.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment244 participants
Primary Completion
Lead SponsorNovo Nordisk A/S
Data Retrieved2026-04-11 02:55:47.366547+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.